TherapeuticsMD Stock Forecast for 2023 - 2025 - 2030
Updated on 04/26/2024
TherapeuticsMD Stock Forecast and Price Target
The average target price set lately by experts for TherapeuticsMD to reach by the end of the year is $2.33, which would imply a potential upside of approximately 3.1 percent from the previous closing price if it were to be achieved. This prediction is based on a high estimate of $2.60 and a low estimate of $2.07. If you want to buy TXMD stock, it might be a good idea to look at its competitors too.
3.10% Upside
TherapeuticsMD Fair Value Forecast for 2023 - 2025 - 2030
In the last zero years, TherapeuticsMD's Price has grown by 100.00%, rising from $0.00 to $0.00. For next year, analysts predict Fair Value of $2.25, which would mean an increase of 100.00%. Over the next twelve years, experts predict that TherapeuticsMD's Fair Value will grow at a rate of 100.00%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
NOVO B Stock Forecast | Novo Nordisk A/S | Outperform |
12
|
kr866.80 | Buy/Sell | kr696.07 | 10.75% |
MRK Stock Forecast | Merck | Outperform |
2
|
$130.72 | Buy/Sell | $130.51 | 7.10% |
ABBV Stock Forecast | AbbVie | Outperform |
9
|
$167.29 | Buy/Sell | $178.42 | 12.98% |
PFE Stock Forecast | Pfizer | Outperform |
2
|
$25.26 | Buy/Sell | $32.87 | 20.74% |
BAYN Stock Forecast | Bayer | Hold |
5
|
26.90€ | Buy/Sell | 45.15€ | 11.52% |
TherapeuticsMD EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last zero years, TherapeuticsMD's EPS has grown by 100.00%, rising from $0.00 to $0.00. For next year, analysts predict EPS of $0.15, which would mean an increase of 100.00%. Over the next twelve years, experts predict that TherapeuticsMD's EPS will grow at a rate of 100.00%.